Upstream Bio, Inc. UPB Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $3.32M+44.7% | $2.85M+20.4% | $2.8M+26.8% | $2.72M+22.6% | $2.3M— | ||
| $147.57M+91.5% | $136.81M+117% | $118.41M+124% | $100.87M+124% | $77.07M— | ||
| $27.71M+38.6% | $26.41M+53.8% | $24.9M+63.4% | $23.43M+75.0% | $19.99M— | ||
| $175.29M+80.6% | $163.22M+104% | $143.31M+111% | $124.29M+113% | $97.06M— | ||
| $175.29M+80.6% | $163.22M+104% | $143.31M+111% | $124.29M+113% | $97.06M— | ||
| -$171.96M-81.5% | -$160.36M-106% | -$140.51M-114% | -$121.57M-116% | -$94.76M— | ||
| -5,176.5%-1,049pp | -5,618.8%-2,338pp | -5,020.1%-2,040pp | -4,464.6%-1,931pp | -4,127.4%— | ||
| $15.24M-2.3% | $16.93M+39.7% | $18.36M+114% | $17.15M+139% | $15.6M— | ||
| $15.2M-2.5% | $16.92M+13.1% | $18.29M+47.7% | $17.1M+8.5% | $15.58M— | ||
| -$156.76M-98.0% | -$143.44M-128% | -$122.23M-129% | -$104.47M-158% | -$79.18M-179% | ||
| -4,719%-1,270pp | -5,026%-2,376pp | -4,366.8%-1,947pp | -3,836.6%-2,013pp | -3,448.7%— | ||
| -$2.90— | -$2.66— | —— | —— | —— | ||
| -$2.90— | -$2.66— | —— | —— | —— | ||
| 215.9M+194% | 215.2M+847% | 175M+1,361% | 124.1M+941% | 73.3M— | ||
| 215.9M+194% | 215.2M+847% | 175M+1,361% | 124.1M+941% | 73.3M— | ||
| -$157.03M-99.3% | -$142.89M-127% | -$122.08M-130% | -$104.16M-157% | -$78.79M— | ||
| -$268K-169% | $555K+1,307% | $142K-66.8% | $313K+10,333% | $389K+1,952% | ||
| —— | —— | -$69K-123% | -$53K-20.5% | -$18K— | ||
| $3.32M+44.7% | $2.85M+20.4% | $2.8M+26.8% | $2.72M+22.6% | $2.3M— | ||
| -$171.96M-81.5% | -$160.36M-106% | -$140.51M-114% | -$121.57M-116% | -$94.76M— | ||
| -$171.77M-81.5% | -$160.17M-106% | -$140.33M-114% | -$121.42M— | -$94.65M— | ||
| -$171.77M-81.5% | -$160.17M-106% | -$140.33M-114% | -$121.42M— | -$94.65M— | ||
| -5,170.7%-1,048pp | -5,612.2%-2,335pp | -5,013.6%-2,036pp | -4,459.2%— | -4,122.2%— | ||
| -$171.96M-81.5% | -$160.36M-106% | -$140.51M-114% | -$121.57M-116% | -$94.76M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Upstream Bio, Inc.'s revenue?
- Upstream Bio, Inc. (UPB) generated $3.3M in revenue over the trailing twelve months, up 44.7% year over year.
- Is Upstream Bio, Inc. profitable?
- Upstream Bio, Inc. is not currently profitable: it reported a net loss of $156.8M over the trailing twelve months, a -4719.0% net margin.
- What is Upstream Bio, Inc.'s earnings per share?
- Upstream Bio, Inc.'s diluted EPS over the trailing twelve months is $-2.90.
- Where does Upstream Bio, Inc.'s income statement data come from?
- Every line is extracted from Upstream Bio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
